Interactive Business Intelligence for Big Data in Life Sciences
Embed Size (px)
Transcript of Interactive Business Intelligence for Big Data in Life Sciences
INTERACTIVE BUSINESS INTELLIGENCE FOR BIG
DATA IN LIFE SCIENCES
Perficient is the leading digital transformation
consulting firm serving Global 2000 and enterprise
customers throughout North America.
With unparalleled information technology, management consulting,
and creative capabilities, Perficient delivers vision, execution, and
value with outstanding digital experience, business optimization,
and industry solutions.
PERFICIENT PROFILEFounded in 1997
Public, NASDAQ: PRFT
2015 revenue ~$473 million
Major market locations:
Allentown, Atlanta, Ann Arbor, Boston, Charlotte, Chattanooga,
Chicago, Cincinnati, Columbus, Dallas, Denver, Detroit, Fairfax,
Houston, Indianapolis, Lafayette, Milwaukee, Minneapolis,
New York City, Northern California, Oxford (UK), Southern California,
St. Louis, Toronto
Global delivery centers in China and India
Dedicated solution practices
~90% repeat business rate
Alliance partnerships with major technology vendors
Multiple vendor/industry technology and growth awards
WELCOME & INTRODUCTION
Senior Solutions Architect
Search and Knowledge Discovery, Perficient
Deep expertise in advanced analytics, business intelligence, Big Data and data
science. Currently working on the convergence and integration of the Internet of
Things (IoT) to improve overall business value.
Big Data in Life Sciences
Scientific, engineering and institutional challenges
Improving long-term access to biomedical data
Using clinical trial results and patients health records
Big Data into point-of-care health-care delivery
How Interactive BI on Big Data can help
The fourth industrial revolution is here
WHY INTERACTIVE BI FOR BIG DATA IN LIFE SCIENCE
Advances in sequencing technology have
triggered a tsunami of genomic data, and
these are joined by waves of information
from other '-omics' studies, clinical trials and
patient records. Analysis of this big data is
launching the era of precision medicine
but enormous scientific, engineering and
institutional challenges remain.
NatureOUTLOOK Vol. 527
No. 7576_supp ppS1-S19
GENOME SEQUENCING AS ROUTINE CLINICAL CARE
Fifteen years ago, it was a landmark
achievement. Ten years ago, it was an
intriguing but highly expensive research
tool. Now, falling costs, soaring accuracy
and a steadily expanding base of scientific
knowledge have brought genome
sequencing to the cusp of routine clinical
PRECISION MEDICINE IS HERE
A growing number of institutions are
conducting genome-wide dragnet
searches to identify the mutations
responsible for rare diseases. Genomic
variants can also reveal driver
mutations that might reveal a tumors
therapeutic vulnerabilities, or provide
clues to whether a specific individual
may or may not respond to a drug
the drugs pharmacogenetic
MAKE IT HAPPEN
Drug companies are facing complex choices. Many are opting to treat cancer, a main thrust
in national programs such as the UK 100,000 Genomes Project. And some of these
therapies are already changing clinical practice.Nature, 2015
Perhaps the most promising product of
big data, that labs will be able to explore
countless and unimagined hypotheses, will
be stymied if we lack the bioinformaticians
that can make this happen.
Jeffrey Chang, University of Texas
IMPROVING LONG-TERM ACCESS TO BIOMEDICAL DATA
How can long-term access to biomedical data that are vital for research beimproved?
Our mission is to use data science to foster an open digital ecosystem that will accelerate efficient, cost-effective biomedical research to enhance health, lengthen life and reduce illness and disability.
Philip Bourne, US National Institutes of Health
USING CLINICAL TRIAL RESULTS, PATIENTS HEALTH RECORDS
How can the barriers to using clinical trial results and patients health records for research be lowered?
Theres a lot of genetic information that no one understands yet, so is it okay or safe or right to put that in the hands of a patient? The flip side is: its my information if I want it, I should get it.
Megan OBoyle, Phelan-McDermid Syndrome Foundation
BIG DATA INTO POINT-OF-CARE HEALTHCARE DELIVERY
How can knowledge from Big Data be brought into point-of-care health-care delivery?
Developing a standard interface for innovators to access the information in electronic health records will connect the point of care to big data and the full power of the web, spawning an app store for health.
Kenneth Mandl, Harvard Medical School
THE FOURTH INDUSTRIAL REVOLUTION
Internet of Things (IoT)
SHOW METHE NUMBERS
The commonality between science and art is in trying to see
profoundly - to develop strategies of seeing and showing.
Beautiful Evidence is about the theory and practice of analytical
The idea of trying to create things that last - forever knowledge -
has guided my work for a long time now.
INTERACTIVE BI ON BIG DATA PART I
Interactive BI on Big Data with TABLEAUhttp://tableau.jethrodata.com/
Interactive BI on Big Data with QLIKhttp://jethrodata.qlik.com
ALL the data, ALL the time at the speed of thought.
CRUNCH THOSE NUMBERS
Make sure you have a comprehensive
solution that meets all your needs.
Crunch the numbers
Show the numbers
Integrate your solution
INTERACTIVE BI ON BIG DATA PART II
THE BIG PICTURE
What is the maturity level of your organization?
What maturity model should you use?
How can you balance analytic insight with the
ability of your organization to make use of the
Can you link analysis to business
outcomes through benefits mapping?
Before investing in advanced analytics,
have you considered alternative
approaches to reaching the same goal?
MAKE THE RIGHT CALL: ADAPT TO SURVIVE
It is not the strongest of the species that survives, nor the most intelligent
that survives. It is the one that is most adaptable to change.
FOLLOW US ONLINE Perficient.com/SocialMedia
February 18, 2016
Interactive Business Intelligence for
Big Data in Life Sciences http://www2.perficient.com/webinar/Interactive-